July 2, 2018
CMIC HOLDINGS Co., Ltd.
CMIC HOLDINGS Co., Ltd. (hereafter”CMIC”) hereby announces that, in relation to the issuance of new shares through third-party allotment as detailed by the “Announcement of Capital and Business Tie-up in CDMO Business between CMIC HOLDINGS Co., Ltd. and Development Bank of Japan Inc. (hereafter”DBJ”)” issued on March 30, 2018, the procedures of payment for the shares were completed today, as outlined below.
In proactively meeting the growing needs of pharmaceutical companies both in Japan and overseas, and expanding business as the platform to manufacture pharmaceutical products, CMIC aims to enhance patients’ Personal Health Value by strengthening our formulation development technologies.
1．Outline of the Subsidiary (Joint Venture) and Issuance of New Shares through Third-Party Allocation
|(1) Company Name||CMIC CMO Co., Ltd.|
|(2) Headquarters||Hamamatsucho Building, 1-1-1 Shibaura, Minato-ku, Tokyo|
|(3) Name and Title of Representative||Makoto Matsukawa, Representative Director and CEO|
|(4) Business Description||Manufacturing, import/export and sales of pharmaceutical products|
|(5) Founded||October 16, 2009|
|(6) Total value of new shares issued||8.5 billion JPY|
|(7) The allotted party||Development Bank of Japan Inc.|
|(8) Payment date||July 2 2018|
|(9) Share-holding before capital increase||CMIC 100.0%|
|(10) Share-holding after capital increase||CMIC 50.4%, DBJ 49.6%|